A detailed history of Gitterman Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gitterman Wealth Management, LLC holds 332 shares of LLY stock, worth $248,339. This represents 0.12% of its overall portfolio holdings.

Number of Shares
332
Previous 332 -0.0%
Holding current value
$248,339
Previous $300,000 2.0%
% of portfolio
0.12%
Previous 0.12%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $196,610 - $263,036
332 New
332 $258,000
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $399,924 - $551,356
920 New
920 $494,000
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $316,127 - $392,866
-1,347 Closed
0 $0
Q4 2021

Feb 01, 2022

BUY
$224.85 - $279.04 $302,872 - $375,866
1,347 New
1,347 $372,000
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $312,456 - $384,521
-1,410 Closed
0 $0
Q2 2021

Jul 30, 2021

BUY
$180.55 - $233.54 $254,575 - $329,291
1,410 New
1,410 $324,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Gitterman Wealth Management, LLC Portfolio

Follow Gitterman Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gitterman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gitterman Wealth Management, LLC with notifications on news.